Breaking News Instant updates and real-time market news.

KDMN

Kadmon

$4.84

0.05 (1.04%)

08:25
02/13/18
02/13
08:25
02/13/18
08:25

Kadmon to host conference call

Conference call to discuss positive top line results from Phase 2 Study of KDO25 in Idiopathic Pulmonary Fibrosis will be held on February 13 at 8:30 am. Webcast Link

  • 13

    Feb

KDMN Kadmon
$4.84

0.05 (1.04%)

02/13/18
JEFF
02/13/18
NO CHANGE
Target $16
JEFF
Buy
Kadmon price target raised to $16 from $9 at Jefferies
Jefferies analyst Biren Amin raised his price target for Kadmon Holdings to $16 after the company announced positive data on its Phase II trial of KD025 in idiopathic pulmonary fibrosis. The absolute improvement of 127 mL between arms surpasses the bar of 45-85 mL seen with existing therapies and the shares should react positively, Amin tells investors in a research note. He keeps a Buy rating on Kadmon shares.
12/21/17
JEFF
12/21/17
NO CHANGE
Target $9
JEFF
Buy
Kadmon Q1 data could bring 'significant' upside, says Jefferies
Jefferies analyst Biren Amin believes Kadmon's Phase II data for KD025 in chronic graft-versus-host disease, expected in Q1 of 2018, represent "significant" upside with little downside risk. KD025 has shown "encouraging activity" in a difficult to treat population, Amin tells investors in a research note. He assumes U.S. market entry of KD025 for treatment of chronic graft-versus-host disease in 2020 and estimates U.S. peak sales of 333.1M. The analyst has a Buy rating on Kadmon shares with a $9 price target.
10/09/17
WBBS
10/09/17
DOWNGRADE
WBBS
Sell
Kadmon downgraded to Sell from Hold at WBB Securities
10/06/17
10/06/17
NO CHANGE

Piper reiterates Overweight on Kadmon after orphan drug designation
Piper analyst Edward Tenthoff noted that Kadmon received FDA orphan drug designation for oral KD025 in chronic Graft-Versus-Host-Disease, or cGVHD, and expects to see additional data at the American Society of Hematology meeting in December. Tenthoff reiterated an Overweight rating and $7 price target on Kadmon shares.

TODAY'S FREE FLY STORIES

BKYI

BIO-key

$2.42

0.02 (0.83%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
BIO-key awarded U.S. patent for Utilization of Biometric Data »

BIO-key International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRON

Cronos Group

$6.77

-0.25 (-3.56%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
Cronos Group granted medicinal cannabis Manufacture License in Australia »

Cronos Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CVS

CVS Health

$67.73

-2.37 (-3.38%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
CVS Pharmacy: Prescription delivery now available nationwide »

CVS Pharmacy, the retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNA

Allena Pharmaceuticals

$13.48

-0.08 (-0.59%)

08:07
06/19/18
06/19
08:07
06/19/18
08:07
Hot Stocks
Allena Pharmaceuticals completes animal proof-of-concept study for ALLN-346 »

Allena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$17.78

0.1 (0.57%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Downgrade
Mattel rating change  »

Mattel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$14.68

2.655 (22.08%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Downgrade
Rent-A-Center rating change  »

Rent-A-Center downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXR

Citius Pharmaceuticals

$2.67

-0.03 (-1.11%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Hot Stocks
Citius Pharmaceuticals announces Mino-Lok is now a registered trademark »

Citius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$6.19

-0.91 (-12.82%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Hot Stocks
IRIDEX announces approval of CYCLO G6 Glaucoma Laser system in Korea »

IRIDEX announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, DIA

Diamonds Fund ETF

$249.72

-0.99 (-0.39%)

08:06
06/19/18
06/19
08:06
06/19/18
08:06
Technical Analysis
Technical Take: Diamonds Fund ETF breaks uptrend support line in pre-market »

As trade war and other…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

DIA

Diamonds Fund ETF

$249.72

-0.99 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RSLS

ReShape Lifesciences

$3.07

-0.05 (-1.60%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
ReShape Lifesciences receives issue notification for ReShape Vest patent »

ReShape Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.55

-0.0816 (-12.92%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Syndicate
Matinas BioPharma raises $8M in a public offering »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISR

IsoRay

$0.45

0.0095 (2.16%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
IsoRay enters one-year employment contract with Lori Woods as Interim CEO »

IsoRay announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSKN

Strata Skin Sciences

$2.11

0.09 (4.46%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Strata announces 510(k) submission for Multi-Micro Dose tip accessory »

STRATA Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$202.60

1.06 (0.53%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Raytheon awarded $161M contract from U.S. Army »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LASR

nLight

$38.51

-0.05 (-0.13%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
nLight analyst commentary  »

nLight price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIBB

Hibbett Sports

$21.70

-0.1 (-0.46%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBNK

First Connecticut

$26.05

0.15 (0.58%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
Breaking Hot Stocks news story on First Connecticut »

First Connecticut trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$97.80

2.93 (3.09%)

, ANSS

Ansys

$177.91

0.17 (0.10%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Recommendations
PTC, Ansys, Rockwell Automation analyst commentary  »

PTC price target raised…

PTC

PTC

$97.80

2.93 (3.09%)

ANSS

Ansys

$177.91

0.17 (0.10%)

ROK

Rockwell Automation

$175.40

-2.19 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

NCR

NCR Corp.

$32.23

0.06 (0.19%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
NCR Corp. announces strategic alliance with TCS »

NCR Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$20.17

0.14 (0.70%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Syndicate
Easterly Government Properties 18M share Spot Secondary priced at $19.25 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

CLBS

Caladrius

$4.05

-0.015 (-0.37%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Caladrius receives FDA RMAT designation for CD34+ cell therapy »

Caladrius Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPO

China Biologic

$99.29

17.39 (21.23%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
China Biologic receives acquisition proposal from CCRE for $110 cash per share »

China Biologic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$114.10

0.215 (0.19%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Initiation
XPO Logistics initiated  »

XPO Logistics resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREX

Trex Company

$64.61

1.675 (2.66%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Trex Company announces effectiveness of 2-for-1 stock split »

Trex Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

G

Genpact

$30.84

-0.095 (-0.31%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Hot Stocks
Genpact awarded patent for natural language understanding by USPTO »

Genpact announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.